$287.5 Million

Twist Bioscience Corporation

Follow-on Offering

Bookrunner, February 2022

Twist Bioscience Corporation

Twist Bioscience Corporation (“Twist” or the “Company”) is a leading synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology, providing DNA for a wide range of uses and markets. The core of their platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip, approximately the size of a large mobile phone. They have combined their silicon-based DNA writing technology with proprietary software, scalable commercial infrastructure and an e-commerce platform to create an integrated technology platform that enables the Company to achieve high levels of quality, precision, automation, and manufacturing throughput at a significantly lower cost than competitors.